We are live on
!
Find out more
VF
Virtu Financial Portfolio holdings
AUM
$2.41B
1-Year Est. Return
48.35%
This Fund
S&P 500
This Quarter
Est. Return
-10.27%
1 Year Est. Return
+48.35%
3 Year Est. Return
+116.81%
5 Year Est. Return
+139.6%
10 Year Est. Return
–
AUM
$1.85B
AUM Growth
+$215M
(+13%)
Cap. Flow
+$467M
Cap. Flow
% of AUM
25.25%
Top 10 Holdings %
Top 10 Hldgs %
43.87%
Holding
2,269
New
792
Increased
360
Reduced
332
Closed
760
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$38.8M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$23.3M |
| 3 |
United States Oil Fund
USO
|
+$16.9M |
| 4 |
DGAZ
VelocityShares 3x Inverse Natural Gas ETN linked to the S&P GSCI Natural Gas Index Excess Return
DGAZ
|
+$11.9M |
| 5 |
Invesco CurrencyShares Canadian Dollar Trust
FXC
|
+$11.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$44.4M |
| 2 |
SPDR Gold Trust
GLD
|
+$24.1M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$23.8M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$20M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$16M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 5.22% |
| 2 | Technology | 4.19% |
| 3 | Energy | 3.73% |
| 4 | Healthcare | 3.61% |
| 5 | Consumer Discretionary | 3.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CYTR
1301
DELISTED
CytRx Corp
CYTR
| $40K | ﹤0.01% |
90,678
+69,444
| +327% | +$47.9K |
|
1302
Acacia Research
ACTG
$451M
| $39K | ﹤0.01% |
13,134
+2,826
| +27% | +$8.74K |
|
1303
Matinas BioPharma
MTNB
$1.68M
| $39K | ﹤0.01% |
+1,296
| New | +$50.9K |
|
1304
Stabilis Solutions
SLNG
$96M
| $38K | ﹤0.01% |
+5,464
| New | +$31.3K |
|
|
KDNY
1305
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $38K | ﹤0.01% |
+2,847
| New | +$56.9K |
|
|
NVCN
1306
DELISTED
Neovasc Inc.
NVCN
| $38K | ﹤0.01% |
+252
| New | +$97.5K |
|
|
CVIA
1307
DELISTED
Covia Holdings Corporation Common Stock
CVIA
| $38K | ﹤0.01% |
+11,097
| New | +$66.9K |
|
1308
CervoMed
CRVO
$41.8M
| $37K | ﹤0.01% |
245
+208
| +562% | +$70.9K |
|
1309
Uranium Energy
UEC
$5.67B
| $37K | ﹤0.01% |
+29,304
| New | +$38.9K |
|
|
NNDM
1310
Nano Dimension
NNDM
$349M
| $36K | ﹤0.01% |
3,262
+275
| +9% | +$4.57K |
|
|
IMMP
1311
Immutep
IMMP
$58M
| $35K | ﹤0.01% |
18,872
-29,844
| -61% | -$83.3K |
|
1312
Lightpath Technologies
LPTH
$822M
| $35K | ﹤0.01% |
23,419
-2,236
| -9% | -$3.94K |
|
|
IDEX
1313
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $35K | ﹤0.01% |
232
-630
| -73% | -$194K |
|
1314
Altimmune
ALT
$583M
| $34K | ﹤0.01% |
+16,274
| New | +$57.6K |
|
1315
Peraso
PRSO
$10.8M
| $34K | ﹤0.01% |
257
+223
| +656% | +$41.5K |
|
1316
Taoping
TAOP
$8.24M
| $34K | ﹤0.01% |
+16
| New | +$34.6K |
|
1317
Actinium Pharmaceuticals
ATNM
$24.9M
| $33K | ﹤0.01% |
2,804
-3,717
| -57% | -$63.4K |
|
1318
Avalon Holdings
AWX
$11.2M
| $33K | ﹤0.01% |
+12,481
| New | +$38.4K |
|
1319
Imunon
IMNN
$6.77M
| $33K | ﹤0.01% |
120
+17
| +17% | +$7.05K |
|
1320
Valhi
VHI
$463M
| $33K | ﹤0.01% |
+1,425
| New | +$35.8K |
|
|
XYLO
1321
DELISTED
Xylo Technologies
XYLO
| $33K | ﹤0.01% |
319
-177
| -36% | -$22.1K |
|
|
INFI
1322
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $33K | ﹤0.01% |
+27,706
| New | +$49.8K |
|
|
ACGN
1323
DELISTED
Aceragen Inc
ACGN
| $33K | ﹤0.01% |
+702
| New | +$80.7K |
|
|
ADXS
1324
DELISTED
Advaxis Inc
ADXS
| $33K | ﹤0.01% |
11,748
+10,350
| +740% | +$79.1K |
|
|
HUSN
1325
DELISTED
Hudson Capital Inc. Ordinary Shares
HUSN
| $33K | ﹤0.01% |
+16,344
| New | +$86K |
|
Similar funds
PUI
DSCM
KFA
RG
QT
GWM
M
EC
Virtu Financial's Q4 2018 Portfolio in Review
As of Q4 2018, Virtu Financial held 2,269 positions worth $1.85B, up 13% from $1.63B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Virtu Financial deployed $467M of net new capital in Q4 2018, opening 792 new positions and adding to 360 existing holdings. Its largest new stake was United States Oil Fund: 167,759 shares worth $13M.
By sector, the portfolio is most concentrated in Financials at 5.2% of assets, down from 9.5% a quarter earlier, followed by Technology and Energy.
On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $23.8M trimmed.
- Virtu Financial's largest Q4 2018 buy was United States Oil Fund: 167,759 shares worth $13M.
- Virtu Financial added most to Vanguard S&P 500 ETF in Q4 2018, an estimated $38.8M increase.
- Virtu Financial's biggest Q4 2018 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $23.8M.
- Virtu Financial fully exited iShares Core S&P 500 ETF in Q4 2018, selling an estimated $44.4M.
- Virtu Financial's ten largest holdings make up 44% of its $1.85B portfolio in Q4 2018.
- Virtu Financial opened 792 new positions and closed 760 in Q4 2018.
- Virtu Financial's portfolio value rose 13% quarter-over-quarter to $1.85B.
Based on Virtu Financial's 13F filing for Q4 2018, filed 16 Jan 2019.